Salih Demir

412 citations
14 papers · 217 indexed · h-index 9
Topics
Acute Lymphoblastic Leukemia research (3 papers)Protein Degradation and Inhibitors (2 papers)Ubiquitin and proteasome pathways (2 papers)
Partner nations
GermanyItalyFrance

In The Last Decade

Salih Demir

12 papers receiving 215 citations

Peers

Salih Demir
Comparison fields: 5 of 62
  • Molecular Biology 120
  • Oncology 52
  • Public Health, Environmental and Occupational Health 47
  • Hematology 40
  • Cancer Research 35
Replace Catherine E. Jenkins with:
Catherine E. Jenkins Canada
Xiaojing Lu China
Himalee S. Sabnis United States
Cecília Correia Portugal
Xiaoxin Hao China
Alexandre Rouette Canada
Andrea Z. Tuckett United States
Florence Zylbersztejn France
Christina Sternberg Austria
Guiping Wan China
Salih Demir relative to Catherine E. Jenkins Canada Catherine E. Jenkins's profile →
Citations per field
00.5×3.7×
Catherine E. Jenkins · 1×
Citations per year

Countries citing papers authored by Salih Demir

Since Specialization
Citations

This map shows the geographic impact of Salih Demir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salih Demir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salih Demir more than expected).

Fields of papers citing papers by Salih Demir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salih Demir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salih Demir. The network helps show where Salih Demir may publish in the future.

Co-authorship network of co-authors of Salih Demir

This figure shows the co-authorship network connecting the top 25 collaborators of Salih Demir. A scholar is included among the top collaborators of Salih Demir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salih Demir. Salih Demir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 0
2 5
3 8
4 0
5 10
6 4
7 11
8 32
9 26
10 24
11 48
12 19
13 17
14 13

About Salih Demir

Salih Demir is a scholar working on Molecular Biology, Biochemistry and Cancer Research, having authored 14 papers that have together received 217 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (3 papers), Protein Degradation and Inhibitors (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Hematology (40 citations), Cancer Research (35 citations) and Oncology (52 citations). Salih Demir has collaborated with scholars based in Germany, Italy and France. Frequent co-authors include Klaus‐Michael Debatin, Lüder Hinrich Meyer, Felix Seyfried, Luca Trentin, Geertruy te Kronnie, Gizem Dinler Doğanay, Hans A. Kestler, Julia Herzig, Johann M. Kraus and Stephan Stilgenbauer. Their work appears in journals such as Blood, Hepatology and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026